Diversified Healthcare Trust
NASDAQ:DHCREIT - Healthcare Facilities
+$0.25 today
- Market cap
- $1.76B
- Beta
- 2.29
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$1.33
- Dividend yield
- 0.45%
Volume 1.69M
Average 1.79M
DHC Net Income
Bottom-line profit after all expenses, interest, and taxes.
Diversified Healthcare TrustNASDAQ: DHC
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income remains negative
Q1 FY2026 net income was -$43.28M, compared with -$8.99M a year earlier. Trailing-twelve-month net income was -$320.18M.
Context
- Net income amounted to 18.6% of revenue in FY2025, down 6.2 pp from a year earlier.
- Net income grew in size in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 3 analysts of -$158.95M (+44.4%) for the fiscal year ending Dec 2026, a step up from the +22.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$43.28M-103.9% QoQ
- Last fiscal yearDec 2025
- -$285.89M+22.8% YoY
- LTMMar 2026
- -$320.18M-9.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -381.6% | +61.4% | +443.0 pp |
| 1 year | +22.8% | +44.4% | +21.6 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the income statement
- Latest · FY2025
- (285.89M) USD
- Year-over-year change
- +22.8%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (285.89M) | +22.8% |
| FY2024 | 2024-12-31 | (370.26M) | -26.1% |
| FY2023 | 2023-12-31 | (293.57M) | -1761.1% |
| FY2022 | 2022-12-31 | (15.77M) | -109.0% |
| FY2021 | 2021-12-31 | 174.52M | — |
Net Income vs competitors
How DHC compares with its peers on the latest reported figures
- DHC's LTM Mar 2026 net income of -$320.18M is the 5th highest of the 7 companies compared; the peer median is -$39.05M.
- Its year-over-year change of -9.3% is the 4th highest of 7, against a peer median of -21.3%.
- Net income amounts to 21.1% of revenue for DHC, versus a peer median of 17.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $142.81M | +16.1% | — | 10.2% | |
| LTM Mar 2026 | $134.62M | -1.9% | — | 18.8% | |
| LTM Mar 2026 | $8.33M | +219.3% | — | 3.1% | |
| LTM Mar 2026 | -$86.42M | -40.7% | — | 15.3% | |
| LTM Mar 2026 | -$320.18M | -9.3% | — | 21.1% | |
| LTM Mar 2026 | -$342.96M | -2309.1% | — | 44.8% | |
| LTM Mar 2026 | -$537.82M | -43.0% | — | 66.0% | |
| Peer median (excluding DHC) | -$39.05M | -21.3% | — | 17.0% | |
Competitors are the stored peer set for DHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.38B | 1.28B | 1.41B | 1.5B | 1.54B |
| Cost of Revenue | 1.09B | 1.11B | 1.19B | 1.24B | 1.78B |
| Gross Profit | 291.4M | 174.5M | 225.3M | 256.38M | (245.33M) |
| Gross Margin | 21.1% | 13.6% | 16.0% | 17.1% | -16.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 34.09M | 26.44M | 26.13M | 26.52M | 45.5M |
| Operating Expenses | 305.22M | 265.72M | 26.13M | 26.52M | (206.07M) |
| Depreciation & Amortization | 271.13M | 239.53M | 283.84M | 285.06M | 261.92M |
| EBITDA | 708.25M | 427.79M | 198.93M | 229.96M | 182.28M |
| EBITDA Margin | 51.2% | 33.3% | 14.1% | 15.4% | 11.9% |
| Operating Income | (13.82M) | (91.22M) | 199.17M | 229.86M | (39.27M) |
| Operating Margin | -1.0% | -7.1% | 14.1% | 15.4% | -2.6% |
| Interest Income | 20.64M | 15.93M | 15.54M | 8.95M | 0 |
| Interest Expense | 255.76M | 209.38M | 191.78M | 235.24M | 204.5M |
| Other Income / Expenses | 195.17M | 76.16M | (492.3M) | (599.65M) | (244.88M) |
| Income Before Tax | 181.36M | (15.06M) | (293.13M) | (369.79M) | (284.14M) |
| Pre-Tax Margin | 13.1% | -1.2% | -20.8% | -24.7% | -18.5% |
| Income Tax Expense | 1.43M | 710K | 445K | 467K | 1.74M |
| Net Income | 174.52M | (15.77M) | (293.57M) | (370.26M) | (285.89M) |
| Net Margin | 12.6% | -1.2% | -20.8% | -24.8% | -18.6% |
| EPS (Basic) | 0.73 | (0.07) | (1.23) | (1.55) | (1.19) |
| EPS (Diluted) | 0.73 | (0.07) | (1.23) | (1.55) | (1.19) |
| Weighted Avg Shares | 237.97M | 238.32M | 238.84M | 239.54M | 240.29M |
| Weighted Avg Shares (Diluted) | 237.97M | 238.31M | 238.84M | 239.54M | 240.29M |
Diversified Healthcare Trust
NASDAQ:DHC
Intrinsic Alpha fair value
Locked
Current Price
$7.24
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.